Gliclazide, a KATP channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Vascular pharmacology

• Publication date

  2018-01-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.vph.2018.01.001PMID 29337033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activated protein C prevents methylglyoxal-induced endoplasmic reticulum stress and cardiomyocyte apoptosis via regulation of the AMP-activated protein kinase signaling pathway.

  2016cited by this paper
• Antagonists of the TMEM16A Calcium-activated Chloride Channel Modulate Airway Smooth Muscle Tone and Intracellular Calcium

  2015cited by this paper
• Alpha Lipoic Acid Modulated High Glucose-Induced Rat Mesangial Cell Dysfunction via mTOR/p70S6K/4E-BP1 Pathway

  2014cited by this paper
• Kir6.2-containing ATP-sensitive K+ channel is required for cardioprotection of resveratrol in mice

  2014cited by this paper
• Leptin promotes KATP channel trafficking by AMPK signaling in pancreatic β-cells

  2013cited by this paper
• Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer

  2013cited by this paper
• ATP and Sulfonylurea Linkage in the KATP Channel Solves a Diabetes Puzzler

  2013cited by this paper
• Glimepiride Treatment Facilitates Ischemic Preconditioning in the Diabetic Heart

  2013cited by this paper
• Effects of sulfonylureas on tumor growth: a review of the literature.

  2013cited by this paper
• Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.

  2013cited by this paper
• Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231

  2013cited by this paper
• AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury.

  2013cited by this paper
• Treating diabetes today with gliclazide MR: a matter of numbers

  2012cited by this paper
• Anti‐proliferative effect of rosiglitazone on angiotensin II‐induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway

  2012cited by this paper
• Down‐regulation of calcium/calmodulin‐dependent protein kinase kinase 2 by androgen deprivation induces castration‐resistant prostate cancer

  2012cited by this paper
• AMP-activated protein kinase connects cellular energy metabolism to KATP channel function.

  2012cited by this paper
• Characterization of the CaMKKβ-AMPK signaling complex.

  2011cited by this paper
• Differential roles for SUR subunits in KATP channel membrane targeting and regulation.

  2011cited by this paper
• Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms

  2010cited by this paper
• Losartan Inhibits Vascular Smooth Muscle Cell Proliferation through Activation of AMP-Activated Protein Kinase.

  2010cited by this paper
• Serine-385 phosphorylation of inwardly rectifying K+ channel subunit (Kir6.2) by AMP-dependent protein kinase plays a key role in rosiglitazone-induced closure of the KATP channel and insulin secretion in rats

  2009cited by this paper
• Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet.

  2009cited by this paper
• K(ATP) channels are involved in regulatory volume decrease in rat cardiac myocytes.

  2009cited by this paper
• Effect of ritonavir on the pharmacodynamics of gliclazide in animal models.

  2009cited by this paper
• Glibenclamide exerts an antitumor activity through reactive oxygen species-c-jun NH2-terminal kinase pathway in human gastric cancer cell line MGC-803.

  2008cited by this paper
• Physiological roles of K+ channels in vascular smooth muscle cells.

  2008cited by this paper
• The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the KATP Channel

  2008cited by this paper
• The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.

  2007cited by this paper
• Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2.

  2007cited by this paper
• Gliclazide inhibits proliferation but stimulates differentiation of white and brown adipocytes.

  2007cited by this paper
• Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.

  2007cited by this paper
• Role of KATP channels in sepsis.

  2006cited by this paper
• Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

  2005cited by this paper
• SNP Analysis of Genes Implicated in T Cell Proliferation in Primary Biliary Cirrhosis

  2005cited by this paper
• The Ca2+/Calmodulin-dependent Protein Kinase Kinases Are AMP-activated Protein Kinase Kinases*

  2005cited by this paper
• Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression

  2005cited by this paper
• Diabetes and insulin secretion: the ATP-sensitive K+ channel (K ATP) connection.

  2005cited by this paper
• Inhibition of Tumor Cell Proliferation by σ Ligands Is Associated with K+ Channel Inhibition and p27kip1 Accumulation

  2004cited by this paper
• AMP-Activated Protein Kinase Inhibits Angiotensin II– Stimulated Vascular Smooth Muscle Cell Proliferation

  2004cited by this paper
• Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes

  2004cited by this paper
• Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.

  2002cited by this paper
• Molecular basis of ATP-sensitive K+ channels in rat vascular smooth muscles.

  2002cited by this paper
• Oral hypoglycemic sulfonylurea glimepiride preserves the myoprotective effects of ischemic preconditioning.

  2002cited by this paper
• Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies

  2002cited by this paper
• Sulfonylurea stimulation of insulin secretion.

  2002cited by this paper
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

  2002cited by this paper
• The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells

  2001cited by this paper
• ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology.

  2000cited by this paper
• ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.

  1998cited by this paper
• ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.

  1998cited by this paper
• Do the K+ channel openers relax smooth muscle by opening K+ channels?

  1993cited by this paper
• Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil

  1990cited by this paper

• Profiles of sulfonylurea use in Diabetes Mellitus type 2: An analysis of clinical practice over the last 10 years.

  2024cites this paper
• Simultaneous HPLC of Metformin, Glipizide and Gliclazide, and Metformin Uptake and Protection of HEI-OC1 from Hyperglycaemia

  2024cites this paper
• Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies

  2023cites this paper
• Gliclazide Reduces Colitis-Associated Colorectal Cancer Formation by Deceasing Colonic Inflammation and Regulating AMPK-NF-κB Signaling Pathway

  2023cites this paper
• Light-stimulated insulin secretion from pancreatic islet-like organoids derived from human pluripotent stem cells.

  2023cites this paper
• Clinical Use of Hydrogen Sulfide to Protect Against Intimal Hyperplasia

  2022cites this paper
• Pharmacodynamic assessment of gliclazide multiparticulate system: single-dose and multiple-dose studies

  2022cites this paper
• Antidiabetic agents: Do they hit the right targets?

  2022cites this paper
• Autophagy-nutrient sensing pathways in diabetic complications.

  2022cites this paper
• Berberine is an insulin secretagogue targeting the KCNH6 potassium channel

  2021cites this paper
• A potential role of calpains in sulfonylureas (SUs) -mediated death of human pancreatic cancer cells (1.2B4).

  2021cites this paper
• The role of potassium in atherosclerosis

  2020cites this paper
• Effect of dihydro-artemisinin on the pharmacokinetics of gliclazide in diabetic subjects

  2020cites this paper
• Mechanism of ATP-sensitive potassium channel opener natal kalin to improve congestive heart failure after myocardial infarction

  2020cites this paper
• Vascular smooth muscle cell senescence and age-related diseases: State of the art.

  2019cites this paper
• AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases

  2019cites this paper
• Mechanisms and characteristics of sulfonylureas and glinides.

  2019cites this paper
• Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation

  2019cites this paper
• Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide

  2018cites this paper